PLDT Inc. PHI
17.20
(0.25)
(1.43%)
as of 25 Sep
- Market cap
- $3.8B
- P/E
- 8.1×
Follow PHI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.27 | 9.16 | 9.38 | 7.89 |
+8 more quarters Free account |
P/S ratio |
1.01 | 1.19 | 1.24 | 1.06 | |
P/FCF ratio |
5.07 | 6.87 | 7.51 | 12.19 | |
P/Operating CF |
10.42 | 11.75 | 11.98 | 8.19 | |
P/B ratio |
1.72 | 2.11 | 2.12 | 1.91 | |
Price to Tangible BV |
3.29 | 4.30 | 4.27 | 4.09 | |
EV/Sales |
2.26 | 2.45 | 2.53 | 2.37 | |
EV/EBITDA |
4.78 | 5.07 | 5.23 | 4.62 | |
EV/Operating CF |
5.18 | 5.54 | 5.60 | 5.80 | |
EV/FCF |
11.34 | 14.07 | 15.38 | 27.29 | |
Quick Ratio |
0.28 | 0.26 | 0.27 | 0.25 | |
Current Ratio |
0.44 | 0.42 | 0.44 | 0.38 | |
Net Debt/EBITDA |
11.02 | 9.36 | 13.12 | 10.84 | |
Debt/Assets |
46.68% | 46.20% | 46.48% | 47.26% | |
Debt/Equity |
2.20 | 2.32 | 2.30 | 2.45 | |
Asset Turnover |
0.35 | 0.35 | 0.35 | 0.35 | |
Operating CF/Net income |
2.93 | 2.57 | 6.76 | 4.08 | |
Capex/Depreciation |
(0.69) | (0.74) | (0.53) | (1.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 32.21% | 105.90% | 0.00% | |
Intangible Assets out of Total Assets |
0.10 | 0.10 | 0.10 | 0.10 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(1.85) | (1.64) | (1.62) | (1.93) | |
Graham Number |
22.04 | 22.70 | 23.15 | 22.83 | |
Earnings Yield |
12.09% | 10.92% | 10.66% | 12.67% | |
Free Cash Flow Yield |
19.72% | 14.56% | 13.31% | 8.21% | |
Revenue per Share |
4.21 | 4.45 | 4.34 | 4.34 | |
Operating CF per Share |
1.68 | 1.79 | 1.82 | 2.28 | |
Capex per Share |
(0.78) | (0.89) | (0.80) | (1.35) | |
Free Cash Flow per Share |
0.90 | 0.90 | 1.02 | 0.94 | |
Cash per Share |
0.92 | 1.18 | 0.97 | 0.88 | |
Shareholders Equity per Share |
10.24 | 10.01 | 10.32 | 9.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.24 | 10.01 | 10.32 | 9.82 | |
Free Cash Flow |
195.22 | 193.53 | 219.71 | 202.95 | |
Working Capital |
(1,542.49) | (1,787.97) | (1,561.30) | (1,775.15) | |
Capital Expenditures |
(168.74) | (193.24) | (172.45) | (291.58) | |
Net Current Asset Value |
(7,029.35) | (7,441.17) | (7,609.58) | (7,807.08) | |
EV/EBIT |
12.92 | 13.25 | 13.27 | 11.02 | |
Capex to Sales |
0.19 | 0.20 | 0.18 | 0.31 | |
Net Profit Margin |
13.65% | 15.69% | 6.19% | 12.91% | |
Price to Operating Income |
5.78 | 6.47 | 6.48 | 4.92 | |
| Other line items | |||||
Average Receivables |
568.04 | 545.48 | 549.50 | 512.85 | |
Average Payables |
974.97 | 975.81 | 1,074.31 | 1,137.35 | |
Average Inventory |
44.86 | 43.55 | 44.96 | 36.37 | |
Average Assets |
10,837.49 | 10,856.90 | 10,976.66 | 10,933.57 | |
Average Common Equity |
2,215.43 | 2,082.47 | 2,126.85 | 2,042.28 |
Columns are period end dates